CZTED 761709-2026published across the EU2 notices, one procedure
Machine translation. The official title is Dodávky léčivých přípravků - Biologika XI.
Fakultní nemocnice Královské Vinohrady, based in Praha, has launched a tender for medical and lab supplies. The contract is estimated at 735,725,000 Kč and runs for 2 years. The buyer has split the job into 7 lots that are awarded separately, so you can bid for the ones that suit your company.
Because this is an open procedure, any qualified company is welcome to submit a bid. All bid documents must be written in Czech and must arrive no later than 26 Nov 2026, 10:00.
Written from the facts of the notice. The official notice is the only binding text.
Fakultní nemocnice Královské Vinohrady draws strong bidding competition. Across 99 known contracts, they average 4 bids per tender, well above the national average of 1.9 for this trade, so price and paperwork need to be sharp. Their latest award was a 51,546,460 Kč contract (“Dodávky léčivých přípravků - Biologika X”), which went to Roche S.r.o. At 735,725,000 Kč, this tender is well above the typical 3,404,641 Kč for this trade nationally. If it is too large for your company alone, you can bid together with a partner.
We base these figures on the award notices we collect: every one we hold for this buyer, plus the last twelve months of awards in this trade across the country.
Do not lose this contract over a missing document. GroundedBid reads the tender documents and lists what the buyer asks of you, each line with the page it comes from.
A paid service provided by tender.zone.Fakultní nemocnice Královské Vinohrady, PrahaTED 758042-2026
Fakultní nemocnice Královské Vinohrady, PrahaTED 763925-2026
In Nov 2026 a contract of this buyer went to Roche S.r.o. for 51,546,460 Kč.
Česká zemědělská univerzita v Praze, PrahaTED 719952-2026
Fakultní nemocnice BrnoTED 715971-2026
Fakultní nemocnice OstravaTED 713678-2026
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.